查看其他139个PD-1 (CD279)抗体 说明书 实验方案 问题与答案 技术支持 货号PA5-35010 Price (CNY) 2,827.00 100 µg 下单后预计有货时间 02-May-2025 查看价格 批量或定制请求 Application Created with Sketch. 图:1/1 PD-1 Antibody (PA5-35010) in Flow ...
PD-1 Monoclonal Antibody (RMP1-30), PE 查看其他139个PD-1 (CD279)抗体 说明书 实验方案 技术支持 货号A14768 此产品已停产 25 µg Application Created with Sketch. 图:1/1 PD-1 Antibody (A14768) in Flow Staining of unstimulated (orange) or ConA-stimulated (purple) splenocytes with 0.5...
Anti-PD-1 Antibody, clone RMP1-14,适应物种:Mouse,应用:Flow Cytometry产品描述:Anti-PD-1 Antibody, clone RMP1-14保存条件:4℃稀释浓度:见说明书产品说明:更快的货期:现货产品一周达。更多的现货:畅销抗体(表观、神经、细胞结构、信号转导等
PD-1TregOsteosarcomaAnti-PD-1 antibodyIFNγ increases PD-L1 expression in osteosarcoma cell lines. Surface markers of human and murine osteosarcoma cell line were evaluated by flow cytometry. The upper row shows representative specimen. In the lower row, each specimen is plotted ( =3), and the...
3、抗PD-1联合抗CTLA-4抗体介导的免疫治疗对黑色素瘤、肾细胞癌和非小细胞肺癌具有显著疗效。4、通过靶向调节免疫反应的途径，如RANK途径，可以将“cold”肿瘤转化为“hot”肿瘤。使用Bio X Cell’s Anti-mouse RANKL (clone IK22/5) antibody，研究人员证明了对RANK通路的抑制将“cold”乳腺肿瘤转化为“hot”...
免疫检查点抗体-PD-1/PD-L1 antibody来源:深圳欣博盛生物科技有限公司 2022年07月15日 10:56 分享 癌症是一个严重的健康问题,也是导致全球发病率和死亡率升高的主要疾病之一。化放疗目前是晚期癌症患者的主要治疗选择,但由于严重的副作用和耐药性而受到限制。因此,非常需要开发新的疗法来克服这些缺点。 癌症...
PD-1 antibody therapy reduced the TI Treg cell numbers, but did not directly restore the cytokine production of TI CD8+ T cells in TC-1 lung cancer. Single-cell analysis indicated that PD-1 signaling promoted lipid metabolism, proliferation and suppressive pathways in TI Treg cells. These ...
Flow cytometry results showed that PD-1 expression was rapidly induced within 48~72 h after activation by the anti-TCR pan-γδ antibody (Supplementary Fig. 1a–c). After the cells were transferred to the wells without coating with anti-TCR pan-γδ antibody, PD-1 expression gradually ...
PD-L1 Rabbit Polyclonal Antibody -20ºC保存,Western一抗稀释液-20ºC或4ºC保存,一年有效。Western一抗稀释液优先推荐4ºC保存,长期不使用可以考虑-20ºC保存,但冻融可能会导致出现轻微的浑浊和少量不溶物。 注意事项: 如果本抗体用于Western blot (WB)、免疫荧光(IF)、免疫细胞化学(ICC)等实验,请...
实际上,PD-1抑制剂对T细胞表面PD-1占有的效果,好的出人意料。 从目前已有的数据来看,不管是国内的还是国外的PD-1抑制剂,也不管半衰期是只有几天,还是几星期的PD-1抑制剂,它们都可以实现在1次注射给药后,在长达数周的时间内稳定维持在70%以上的PD-1...